Cargando…

Prevalence of latex allergy in spina bifida patients in Singapore

BACKGROUND: Latex allergy and its clinical presentation are rising in prevalence across the globe, especially amongst patients with spina bifida (SB). While studies have been well-established in Europe and America, data from Asia are limited. OBJECTIVE: The aim of this study is to investigate the sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Xiuzhen, Mohamed, Javid, van Bever, Hugo PS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643061/
https://www.ncbi.nlm.nih.gov/pubmed/23667832
http://dx.doi.org/10.5415/apallergy.2013.3.2.96
_version_ 1782268256691683328
author Chua, Xiuzhen
Mohamed, Javid
van Bever, Hugo PS
author_facet Chua, Xiuzhen
Mohamed, Javid
van Bever, Hugo PS
author_sort Chua, Xiuzhen
collection PubMed
description BACKGROUND: Latex allergy and its clinical presentation are rising in prevalence across the globe, especially amongst patients with spina bifida (SB). While studies have been well-established in Europe and America, data from Asia are limited. OBJECTIVE: The aim of this study is to investigate the scenario in Singapore. METHODS: 35 subjects with SB, aged 5 to 32 years answered a questionnaire and underwent skin prick test (SPT) using a latex solution, 3 common house dust mites and 3 commonly cross-reacting food allergens (banana, kiwi and avocado). We also noted the relation between latex sensitization with atopy and doctor-diagnosed allergy. The prevalence of cross-reactivity with fruits was also studied. RESULTS: Sensitization to latex (i.e. a positive SPT) was found in 16 (46%, 95% confidence interval 29%-63%) of the subjects. Only 5 (31%) of the subjects who were sensitized to latex had clinical manifestations. Atopy (i.e. positive SPT to house dust mites) was present in 23 (66%) of the subjects and 13 (57%) of them was also sensitized to latex. There was a positive trend between latex sensitization and atopy (81.2% vs. 52.6%, p = 0.076), as well as latex sensitization with those having both atopy and doctor-diagnosed allergy (i.e. asthma, allergic rhinitis, eczema, drug allergy) (93.8% vs. 63.2%, p = 0.032). Only 6 (38%) subjects had allergy to the food allergens tested. CONCLUSION: Almost half of the SB patients in Singapore are sensitized to latex. This number is comparable to that in Europe and America. Positive trend between latex sensitization and those with both atopy and doctor-diagnosed allergy (p = 0.032) is suggestive of a possible cause-effect relationship.
format Online
Article
Text
id pubmed-3643061
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Asia Pacific Association of Allergy, Asthma and Clinical Immunology
record_format MEDLINE/PubMed
spelling pubmed-36430612013-05-10 Prevalence of latex allergy in spina bifida patients in Singapore Chua, Xiuzhen Mohamed, Javid van Bever, Hugo PS Asia Pac Allergy Original Article BACKGROUND: Latex allergy and its clinical presentation are rising in prevalence across the globe, especially amongst patients with spina bifida (SB). While studies have been well-established in Europe and America, data from Asia are limited. OBJECTIVE: The aim of this study is to investigate the scenario in Singapore. METHODS: 35 subjects with SB, aged 5 to 32 years answered a questionnaire and underwent skin prick test (SPT) using a latex solution, 3 common house dust mites and 3 commonly cross-reacting food allergens (banana, kiwi and avocado). We also noted the relation between latex sensitization with atopy and doctor-diagnosed allergy. The prevalence of cross-reactivity with fruits was also studied. RESULTS: Sensitization to latex (i.e. a positive SPT) was found in 16 (46%, 95% confidence interval 29%-63%) of the subjects. Only 5 (31%) of the subjects who were sensitized to latex had clinical manifestations. Atopy (i.e. positive SPT to house dust mites) was present in 23 (66%) of the subjects and 13 (57%) of them was also sensitized to latex. There was a positive trend between latex sensitization and atopy (81.2% vs. 52.6%, p = 0.076), as well as latex sensitization with those having both atopy and doctor-diagnosed allergy (i.e. asthma, allergic rhinitis, eczema, drug allergy) (93.8% vs. 63.2%, p = 0.032). Only 6 (38%) subjects had allergy to the food allergens tested. CONCLUSION: Almost half of the SB patients in Singapore are sensitized to latex. This number is comparable to that in Europe and America. Positive trend between latex sensitization and those with both atopy and doctor-diagnosed allergy (p = 0.032) is suggestive of a possible cause-effect relationship. Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2013-04 2013-04-26 /pmc/articles/PMC3643061/ /pubmed/23667832 http://dx.doi.org/10.5415/apallergy.2013.3.2.96 Text en Copyright © 2013. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Chua, Xiuzhen
Mohamed, Javid
van Bever, Hugo PS
Prevalence of latex allergy in spina bifida patients in Singapore
title Prevalence of latex allergy in spina bifida patients in Singapore
title_full Prevalence of latex allergy in spina bifida patients in Singapore
title_fullStr Prevalence of latex allergy in spina bifida patients in Singapore
title_full_unstemmed Prevalence of latex allergy in spina bifida patients in Singapore
title_short Prevalence of latex allergy in spina bifida patients in Singapore
title_sort prevalence of latex allergy in spina bifida patients in singapore
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643061/
https://www.ncbi.nlm.nih.gov/pubmed/23667832
http://dx.doi.org/10.5415/apallergy.2013.3.2.96
work_keys_str_mv AT chuaxiuzhen prevalenceoflatexallergyinspinabifidapatientsinsingapore
AT mohamedjavid prevalenceoflatexallergyinspinabifidapatientsinsingapore
AT vanbeverhugops prevalenceoflatexallergyinspinabifidapatientsinsingapore